March 13, 2023 – Page 2 – Columbus News Online

Archive

Candidemia Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Companies – Cidara Therapeutics, Mundipharma, Pfizer

The Candidemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Candidemia pipeline products will significantly revolutionize the

Vasomotor Symptoms of Menopause Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Vasomotor Symptoms pipeline constitutes 9+ key companies continuously working towards developing 9+ Vasomotor Symptoms treatment therapies, analysis of Clinical

Fuchs Endothelial Corneal Dystrophy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Kowa Pharmaceuticals, Trefoil

The Fuchs Endothelial Corneal Dystrophy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Fuchs Endothelial Corneal Dystrophy

Keratoconus Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – Glaukos Corporation, iVeena Delivery Systems, Inc., Laboratoires Thea

The Keratoconus market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Keratoconus pipeline products will significantly revolutionize the

Dystrophic Epidermolysis Bullosa Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Las Vega (Nevada), United States //— As per DelveInsight’s assessment, globally, Dystrophic Epidermolysis Bullosa pipeline constitutes 15+ key companies continuously working towards developing 15+ Dystrophic Epidermolysis Bullosa treatment therapies, analysis

Retinal Vein Occlusion Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – Taiwan Liposome Company, Aerie Pharmaceuticals

The Retinal Vein Occlusion market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Retinal Vein Occlusion pipeline products

Global Artificial Intelligence (AI) In Drug Discovery Market to Grow at a CAGR of 37.67% by 2027, Estimates DelveInsight | Key Companies – IBM, NuMedii, Deep Genomics, NVIDIA., Atomwise, Insilico

Las Vega (Nevada), United States – The Artificial Intelligence (AI) In Drug Discovery Market is expected to grow in the coming years owing to the factors such as the rising

Global Biologics Market to Register Growth at a CAGR of 9.59% by 2027, Estimates DelveInsight | Key Companies – GSK, Eli Lilly, Roche, AbbVie, Amgen, Sanofi, Merck, Novartis, Pfizer, AstraZeneca

Las Vega (Nevada), United States – The global Biologics Market was valued at USD 333.10 billion in 2021 and growing at a CAGR of 9.59% during the forecast period (2022

Myelofibrosis Emerging and Marketed Drugs Assessment, (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 45+ key pharma and biotech companies are working on 45+ pipeline drugs in the Myelofibrosis therapeutics landscape based on different Routes

Beta-thalassemia (B-thal) Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies – Phoenicia, EdiGene, Imara, Agios, Ionis

Delveinsight Business Research LLP As per DelveInsight, the Beta-thalassemia Market is anticipated to evolve immensely in the coming years owing to the rise in the prevalence of Beta-thalassemia and the

Archive

Loading, Please Wait!